Cite
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
MLA
Zakrzewski, Johannes L., et al. “Tumor Immunotherapy across MHC Barriers Using Allogeneic T-Cell Precursors.” Nature Biotechnology, vol. 26, no. 4, Apr. 2008, pp. 453–61. EBSCOhost, https://doi.org/10.1038/nbt1395.
APA
Zakrzewski, J. L., Suh, D., Markley, J. C., Smith, O. M., King, C., Goldberg, G. L., Jenq, R., Holland, A. M., Grubin, J., Cabrera-Perez, J., Brentjens, R. J., Lu, S. X., Rizzuto, G., Sant’Angelo, D. B., Riviere, I., Sadelain, M., Heller, G., Zúñiga-Pflücker, J. C., Chen Lu, & van den Brink, M. R. M. (2008). Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology, 26(4), 453–461. https://doi.org/10.1038/nbt1395
Chicago
Zakrzewski, Johannes L., David Suh, John C. Markley, Odette M. Smith, Christopher King, Gabrielle L. Goldberg, Robert Jenq, et al. 2008. “Tumor Immunotherapy across MHC Barriers Using Allogeneic T-Cell Precursors.” Nature Biotechnology 26 (4): 453–61. doi:10.1038/nbt1395.